Key result
Within 4 years after carotid endarterectomy, type 2 diabetes was an independent risk factor for major adverse events (HR 1.62) compared to non-diabetic patients.
Why the study?
The study aimed to compare early and late outcomes after CEA between Korean type 2 diabetic and non-diabetic patients, and to evaluate the impact of diabetes on post-CEA cardiovascular events.
Does type 2 diabetes increase the risk of major adverse events in patients with significant carotid stenosis undergoing carotid endarterectomy?
Cohort (n=613)
No
Does type 2 diabetes increase the risk of major adverse events in patients with significant carotid stenosis undergoing carotid endarterectomy?
Hazard Ratio: 1.62 (95% CI 1.06–2.48)
Absolute Event Rate: 15.8% vs 10.5%
p-value: p=0.026
Type 2 diabetes is an independent risk factor for late (4-year) major adverse events and stroke after carotid endarterectomy, despite similar perioperative risks compared to non-diabetic patients.
BACKGROUND: We aimed to compare early and late outcomes after carotid endarterectomy (CEA) between Korean type 2 diabetic and non-diabetic patients and to investigate the impact of diabetes on the overall incidence of cardiovascular events after CEA. METHODS: We retrospectively analyzed 675 CEAs, which were performed on 613 patients with significant carotid stenosis between January 2007 and December 2014. The CEAs were divided into a type 2 diabetes mellitus (DM) group (n = 265, 39.3%) and a non-DM group (n = 410, 60.7%). The study outcomes included the incidence of major adverse events (MAEs), defined as fatal or nonfatal stroke or myocardial infarction or all-cause mortality, during the perioperative period and within 4 years after CEA. RESULTS: Patients in the DM and non-DM groups did not differ significantly in the incidence of MAEs or any of the individual MAE manifestations during the perioperative period. However, within 4 years after CEA, the difference in the MAE incidence was significantly greater in the DM group (P = 0.040). Analysis of the individual MAE manifestations indicated a significantly higher risk of stroke in the DM group (P = 0.006). Multivariate analysis indicated that diabetes was not associated with MAEs or individual MAE manifestations during the perioperative period, whereas within 4 years after CEA, diabetes was an independent risk factor for MAEs overall (hazard ratio [HR], 1.62; 95% confidence interval [CI] 1.06-2.48; P = 0.026) and stroke (HR, 2.55; 95% CI 1.20-5.41; P = 0.015) in particular. CONCLUSIONS: Diabetic patients were not at greater risk of perioperative MAEs after CEA; however, the risk of late MAE occurrence was significantly greater in these patients. Within 4 years after CEA, DM was an independent risk factor for the occurrence of MAEs overall and stroke in particular.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2019) conducted a cohort in Significant carotid stenosis (n=613). Type 2 Diabetes Mellitus vs. Non-diabetic patients was evaluated on Major adverse events (fatal or nonfatal stroke, myocardial infarction, or all-cause mortality) within 4 years (HR 1.62, 95% CI 1.06-2.48, p=0.026). Within 4 years after carotid endarterectomy, type 2 diabetes was an independent risk factor for major adverse events (HR 1.62) compared to non-diabetic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: